Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Using psychological treatments can help manage skin conditions along with regular medical care.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Ruxolitinib can help regrow hair in severe alopecia areata.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

New treatments are available for managing ingrown hair inflammation.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Selenium sulfide in anti-dandruff shampoos can turn hair green.

A girl with Netherton syndrome was able to eat wheat without allergies after a special treatment.

Eating Citrullus colocynthis can cause severe intestinal bleeding and damage.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

The Edwardian medical campaign linked maternal drinking to infant mortality and national decline, influencing hygiene education and leading to a ban on children under 14 from pubs.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

The study concluded that the most common skin changes in elderly people are wrinkles and dry skin, with various infections, benign tumors, and changes in nails and hair also being significant.

Galla chinensis solution effectively treats fungal skin infections in dogs.

The polyherbal hair oil effectively reduces dandruff and promotes hair growth.

The conclusion is that advertising is a key part of "The Pickwick Papers," reflecting the consumer culture of Victorian Britain.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.